These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4801443)

  • 1. [Proceedings: Adverse effects in 3 different mestranol-norethisterone administrations].
    Jacobs C; Heinen G; Umla H
    Arch Gynakol; 1973 Sep; 214(1):257-8. PubMed ID: 4801443
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical study of S-3800E tablets, a combination of norethindrone and mestranol in a small dosage].
    Tokuda G; Murakami A; Higashiyama S; Obata T; Ishihara S
    Saishin Igaku; 1969 Mar; 24(3):644-56. PubMed ID: 5772841
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical effects of norethisterone and mestrano mixture (Sophid-32) in a low dosage].
    Okada K; Yoshizaki S; Ozawa H
    Sanfujinka No Jissai; 1970 Jan; 19(1):98-102. PubMed ID: 5467334
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of an estroprogestinic association (norethindrone 2 mg and mestranol 100 gamma) in dysfunctional gynecologic syndromes].
    Capra A; Trompeo P; Garetto A; Campagnoli C
    Minerva Ginecol; 1969 Aug; 21(15):967-86. PubMed ID: 5404341
    [No Abstract]   [Full Text] [Related]  

  • 5. [Evaluation of the efficacy and side effects of the contraceptive containing 0.5 mg of norethindrone and 0.1 mg of mestranol in a family planning clinic].
    de Sampaio Júnior LF; Dib JE; Pereira VM; Neme B
    Matern Infanc (Sao Paulo); 1971; 30(1):65-9. PubMed ID: 5135370
    [No Abstract]   [Full Text] [Related]  

  • 6. [Contraception with two low-dosage mestranol-norethisterone combinations].
    Tenhaeff D; Feldmann HU; Rupek R
    Fortschr Med; 1972 Apr; 90(12):479-82. PubMed ID: 4641330
    [No Abstract]   [Full Text] [Related]  

  • 7. Norinyl 1+80 and Ortho-Novum 1/80.
    Med Lett Drugs Ther; 1969 Apr; 11(8):35. PubMed ID: 5778361
    [No Abstract]   [Full Text] [Related]  

  • 8. The relationship of clotting factors to dosage levels of estrogen and progestogen-like combinations.
    Banks AL; Rutherford RN; Coburn WA; Welsh RL
    Int J Fertil; 1966; 11(3):277-80. PubMed ID: 5967993
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical use of combined tablets of norethisterone 1.0 mg and mestranol.05 mg].
    Domon H; Washizuka N; Ishikawa M
    Horumon To Rinsho; 1969 Feb; 17(2):133-6. PubMed ID: 5815262
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical application of Sophia-A, combined low-dosage preparation of norethisterone and mestranol].
    Akasu F; Akasofu K; Hayashi I; Fujii I; Shimada H
    Horumon To Rinsho; 1969 Oct; 17(10):871-5. PubMed ID: 5390548
    [No Abstract]   [Full Text] [Related]  

  • 11. [Jaundice following norethisterone plus mestranol (Plan)].
    Nielsen JA
    Ugeskr Laeger; 1970 Nov; 132(46):2176-8. PubMed ID: 5487344
    [No Abstract]   [Full Text] [Related]  

  • 12. Control of fertility with oral medication.
    Diddle AW; Watts GF; Gardner WH; Williamson PJ
    West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale for a new triphasic oral contraceptive.
    Pasquale SA
    Int J Fertil; 1986; 31 SU [UPDATE]():13-9. PubMed ID: 2899554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term evaluation of two oral contraceptives.
    Hutcherson WP; Schwartz HA; Weathers W; McGuire JE
    Fertil Steril; 1967; 18(5):616-31. PubMed ID: 6037450
    [No Abstract]   [Full Text] [Related]  

  • 15. Types of oral contraceptives, depression, and premenstrual symptoms.
    Kutner SJ; Brown WL
    J Nerv Ment Dis; 1972 Sep; 155(3):153-62. PubMed ID: 4403361
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experimental use of ST-613 (norethisterone 1.Omg plus mestranol 0.05mg].
    Iwata K
    Horumon To Rinsho; 1970 May; 18(5):421-2. PubMed ID: 5465537
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hepatotoxic effect of 2 anovulatory steroids, mestranol and norethisterone acetate in the rat].
    Brignone JA; De Brignone CM; De Dávila MT; Koch O; Stoppani AO
    Medicina (B Aires); 1979; 39(4):477-88. PubMed ID: 161795
    [No Abstract]   [Full Text] [Related]  

  • 18. Pathologic changes in the human urinary tract due to anovulatory drug administration.
    Corriere JN
    J Surg Oncol; 1973; 5(2):167-74. PubMed ID: 4703842
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative study of the effects of two once-a-month injectable contraceptives (Cyclofem and Mesigyna) and one oral contraceptive (Ortho-Novum 1/35) on coagulation and fibrinolysis.
    United Nations Development Programme/United Nations Population Fund/World Health Organization/World Bank Special Programme of Research, Development and Research Training in Human Reproduction, Task Force on Long-acting Systemic Agents for Fertility Regulaion
    Contraception; 2003 Sep; 68(3):159-76. PubMed ID: 14561536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [First case of steroid jaundice caused by norethindrone and mestranol in Japan].
    Hayashi K; Okamura H; Nishikawa Y; Miura Y; Ashidaka Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1966 Dec; 18(12):1461-4. PubMed ID: 6009965
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.